TOLREMO therapeutics

TOLREMO therapeutics

TOLREMO therapeutics

TOLREMO therapeutics AG is an ETH spinoff focused on the discovery and development of small molecules to prevent resistance in cancer therapy.
Raised
$9.3M
Follow us
Alexa global traffic share